Anebulo Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 22NW, LP | 11/14/2025 | 15.47 M | $38.67 M | 0.00% | 45.73% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 3.04 M | $7.59 M | 0.00% | 8.98% |
| MANGROVE PARTNERS | 11/14/2025 | 2.53 M | $6.31 M | 0.00% | 7.47% |
| MORGAN STANLEY | 11/14/2025 | 399.40 K | $998.51 K | 0.05% | 1.18% |
| VANGUARD GROUP INC | 11/07/2025 | 306.54 K | $766.35 K | 41.95% | 0.91% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 174.11 K | $435.57 K | -15.37% | 0.51% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 157.72 K | $394.30 K | 0.00% | 0.47% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 28.50 K | $71.25 K | 100.00% | 0.08% |
| NORTHERN TRUST CORP | 11/14/2025 | 24.39 K | $60.98 K | 100.00% | 0.07% |
| BLACKROCK, INC. | 11/12/2025 | 24.06 K | $60.15 K | 39.78% | 0.07% |
| RANGELEY CAPITAL, LLC | 11/14/2025 | 20.00 K | $50.00 K | 100.00% | 0.06% |
| XTX TOPCO LTD | 11/14/2025 | 19.15 K | $47.88 K | 100.00% | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 18.84 K | $47.09 K | 0.00% | 0.06% |
| STATE STREET CORP | 11/14/2025 | 12.77 K | $31.92 K | 100.00% | 0.04% |
| JPMORGAN CHASE & CO | 11/26/2025 | 2.14 K | $5.35 K | 100.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.75 K | $4.38 K | -46.19% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 891 | $2.23 K | -74.43% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 399 | $998 | 100.00% | 0.00% |
| UBS GROUP AG | 11/13/2025 | 220 | $550 | 139.13% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 6 | $15 | 100.00% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 11/07/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| LVW ADVISORS, LLC | 10/20/2025 | 0 | $0 | -100.00% | 0.00% |
| AMERITAS ADVISORY SERVICES, LLC | 11/06/2025 | 0 | $0 | -100.00% | 0.00% |
Anebulo Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 26 institutional investors and hedge funds held shares of Anebulo Pharmaceuticals, Inc.. The most heavily invested institutionals were:
22NW, LP: 15.47 M
Nantahala Capital Management, LLC: 3.04 M
MANGROVE PARTNERS: 2.53 M
MORGAN STANLEY: 399,404
VANGUARD GROUP INC: 306,540
GEODE CAPITAL MANAGEMENT, LLC: 174,108
65.70% of Anebulo Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 22.22 M shares in the last 24 months. This purchase volume represents approximately $52.23 M in transactions.